Login / Signup

TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.

John A MackintoshMaria PietschViviana LutzkyDebra EneverSandra BancroftSimon H ApteMaxine TanStephanie T YerkovichJoanne L DickinsonHilda A PickettHiran SelvaduraiChristopher GraingeNicole S GohPeter HopkinsIan GlaspolePaul N ReynoldsJeremy WrobelAdam JaffeTamera J CorteDaniel C Chambers
Published in: BMJ open respiratory research (2021)
NCT04638517; Australian New Zealand Clinical Trials Registry (ACTRN12620001363976p).
Keyphrases
  • placebo controlled
  • double blind
  • clinical trial
  • pulmonary fibrosis
  • phase ii
  • phase iii
  • study protocol
  • open label
  • phase ii study
  • randomized controlled trial